CryoPort (FRA:CKX) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CKX CryoPort Inc FRA:CKX
69 GF Score
Price €14.10
GF Value €9.43
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is CryoPort Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:CKX
69GF Score
CryoPort Inc FRA:CKX
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CryoPort (FRA:CKX) Overvalued in 2026?

Based on GuruFocus' analysis, CryoPort stock appears to be overvalued. The current stock price of €14.10 is trading 49.5% above its estimated GF Value™ of €9.43. GuruFocus considers CryoPort to be Significantly Overvalued.

Key valuation signals for FRA:CKX:

  • Dividends Received:
  • GF Value™: €9.43 vs. price of €14.10 (49.5% above fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the FRA:CKX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CryoPort Business Description

Other Exchanges CYRX:USA
Address 112 Westwood Place, Suite 350, Brentwood, TN, USA, 37027
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
69GF Score

Get the complete analysis for FRA:CKX

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.10
Price
€9.43
GF Value